NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE76911 Query DataSets for GSE76911
Status Public on Dec 27, 2016
Title Catalogue of genomic alterations in uterine cervical carcinoma of Indian patients.
Organism Homo sapiens
Experiment type Genome variation profiling by genome tiling array
Genome variation profiling by SNP array
Summary To identify genomic alterations in uterine cervical carcinoma of Indian patients. Cancer of the uterine cervix (CACX) is the fourth most frequent carcinoma among women worldwide. In India, it accounts for approximately 132,000 new cases and 74,000 deaths annually contributing to nearly 1/3rd of the global cervical cancer deaths. Although, several etiological factors such as use of oral contraceptives, precocious marriage, multiparity, smoking etc. are seen to modify the risk of CACX, but infection by high risk human papillomavirus (hrHPV) is thought to be the major cause. Interestingly, long latency period for malignant outcome in only a subset of HPV-infected women indicates involvement of additional chromosomal alterations.Since the first report of changes in chromosomal content of CACX, several genome-wide studies reported frequent chromosomal gain of 3q (3q24–29), 1q (1q22–q23, 1q25.3–q32.1) and 5p (5p12–p13) and loss of 3p (3p12–23), 11q (11q22.3–25) and 4p (4p16.3–p16.1). But no study was done to catalogue the precise genomic alterations in CACX of Indian patients. To the best of our knowledge, for the first time the present study revealed precise chromosomal aberrations with differential frequency in Indian CACX patients (n=11). Among these alterations, frequent (>50%) amplifications of distinct chromosomal loci were as follows: 1p36.11-1p31.1, 1q21.1-1q44, 3q13.13-3q29, 5p15.33-5p12, 8q24.3, 16q22.2, 19q13.13-19q13.2, Xp22.33-Xp11.21 and Xq11.2-Xq12. While recurrent (>35%) loss at chromosomal loci, 2q34-2q37.3, 4p16.3-4p12, 4q21.3, 8p23.3, 8p23.2, 8p11.22, 11q14.1-11q25, 13q13.3-13q14.3, and 19p13.3 were also observed. All CACX patients showed precise amplification of chromosome 3 at coordinates 3q25.2-3q26.1 (chr3:154427429-162796745), 3q26.1-3q26.31 (chr3:162901354-175146595) and 3q26.32-3q29 (chr3:175208719-198094926). Highest (72%) loss of chromosomal loci 11q24.3-11q25 (chr11:128926744-135034169) was seen.
 
Overall design Agilent two-color CGH+SNP experiment,Organism: Human ,Agilent Human CGH+SNP 2X400K Array (AMADID: 028081)
Web link http://www.sciencedirect.com/science/article/pii/S0304416516303506
 
Contributor(s) Roychowdhury A, Samadder S, Roychoudhury S, Panda CK
Citation(s) 27641506
Submission date Jan 15, 2016
Last update date Feb 23, 2017
Contact name Susanta Roychoudhury
E-mail(s) anirbanr91@gmail.com
Organization name Saroj Gupta Cancer Centre & Research Institute
Street address Mahatma Gandhi Road, Thakurpukur
City Kolkata
State/province West Bengal
ZIP/Postal code 700063
Country India
 
Platforms (1)
GPL11363 Agilent-028081 Human Genome CGH + SNP Microarray (Probe Name version)
Samples (12)
GSM2040579 Primary Tumor vs matched normal blood_Cervical cancer patient_#1960
GSM2040580 matched normal blood_#854 vs. normal Coriell Sample (Coriell_NA12878)-European_Female
GSM2040581 Primary Tumor vs matched normal blood_Cervical cancer patient_#4253
Relations
BioProject PRJNA308930

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE76911_RAW.tar 1.3 Gb (http)(custom) TAR (of TXT)
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap